{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Ogundeji AO"],"funding":["National Research Foundation of South Africa"],"pagination":["404"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC8146328"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["14(5)"],"pubmed_abstract":["Photodynamic treatment (PDT) is often successful when used against aerobic microbes, given their natural susceptibility to oxidative damage. To this end, the current study aimed to explore the photodynamic action of acetylsalicylic acid (ASA; aspirin, which is commonly used to treat non-infectious ailments), when administered to respiring cryptococcal cells. The treatment of cryptococcal cells, i.e., exposure to 0.5 or 1 mM of ASA in the presence of ultraviolet light (UVL) for 10 min, resulted in a significant (<i>p</i> < 0.05) reduction in the growth of tested cells when compared to non-treated (non-Rx) cells, i.e., no ASA and no UVL. The treated cells were also characterised by diseased mitochondria, which is crucial for the survival of respiring cells, as observed by a significant (<i>p"],"journal":["Pharmaceuticals (Basel, Switzerland)"],"pubmed_title":["The Repurposing of Acetylsalicylic Acid as a Photosensitiser to Inactivate the Growth of Cryptococcal Cells."],"pmcid":["PMC8146328"],"funding_grant_id":["UID 114321"],"pubmed_authors":["Sebolai OM","Pohl CH","Folorunso OS","Ogundeji AO","Mjokane N","Nyaga MM"],"additional_accession":[]},"is_claimable":false,"name":"The Repurposing of Acetylsalicylic Acid as a Photosensitiser to Inactivate the Growth of Cryptococcal Cells.","description":"Photodynamic treatment (PDT) is often successful when used against aerobic microbes, given their natural susceptibility to oxidative damage. To this end, the current study aimed to explore the photodynamic action of acetylsalicylic acid (ASA; aspirin, which is commonly used to treat non-infectious ailments), when administered to respiring cryptococcal cells. The treatment of cryptococcal cells, i.e., exposure to 0.5 or 1 mM of ASA in the presence of ultraviolet light (UVL) for 10 min, resulted in a significant (<i>p</i> < 0.05) reduction in the growth of tested cells when compared to non-treated (non-Rx) cells, i.e., no ASA and no UVL. The treated cells were also characterised by diseased mitochondria, which is crucial for the survival of respiring cells, as observed by a significant (<i>p","dates":{"release":"2021-01-01T00:00:00Z","publication":"2021 Apr","modification":"2026-04-08T08:37:42.137Z","creation":"2022-02-10T14:36:03.31Z"},"accession":"S-EPMC8146328","cross_references":{"pubmed":["33922831"],"doi":["10.3390/ph14050404"]}}